(1)
K, R. S.; K.P.R, C. FORMULATION DEVELOPMENT OF EFAVIRENZ TABLETS EMPLOYING Β CYCLODEXTRIN, SOLUPLUS AND PVP K30: FACTORIAL STUDY. irjpas 2013, 3, 110-115.